Sitagliptin (DPP-4 Inhibitor)-induced Rheumatoid Arthritis in Type 2 Diabetes Mellitus: A Case Report-Reference-Cited by-同舟云学术

Sitagliptin (DPP-4 Inhibitor)-induced Rheumatoid Arthritis in Type 2 Diabetes Mellitus: A Case Report

Published:2012 Issue:15 Volume:51 Page:2041-2044
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yokota Kazuki¹²,Igaki Naoya²

Affiliation:

1. Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Japan

2. Department of Internal Medicine, Takasago Municipal Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/51/15/51_51.7592/_pdf

Reference16 articles.

1. 1. Busso N, Wagtmann N, Herling C, et al. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol 166: 433-442, 2005.

2. 2. The Committee of Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Journal of Diabetes Investigation 1: 212-228, 2010.

3. 3. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69: 1580-1588, 2010.

4. 4. Muscat C, Bertotto A, Agea E, et al. Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients. Clin Exp Immunol 98: 252-256, 1994.

5. 5. Cordero OJ, Salgado FJ, Mera-Varela A, Nogueira M. Serum interleukin-12, interleukin-15, soluble CD26, and adenosine deaminase in patients with rheumatoid arthritis. Rheumatol Int 21: 69-74, 2001.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive safety profile of dipeptidyl peptidase-4 inhibitors: a post-marketing study based on FAERS database using signal detection algorithms;Expert Opinion on Drug Safety;2024-04-23

2. Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors;Journal of Inflammation Research;2024-03

3. Identification of levomenthol derivatives as potential dipeptidyl peptidase-4 inhibitors: a comparative study with gliptins;Journal of Biomolecular Structure and Dynamics;2023-06-01

4. Glucose as a Potential Key to Fuel Inflammation in Rheumatoid Arthritis;Nutrients;2022-06-04

5. Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease;Frontiers in Immunology;2022-03-04